Corrigendum to “Comparison of [17(20)E]-21-Norpregnene oxazolinyl and benzoxazolyl derivatives as inhibitors of CYP17A1 activity and prostate carcinoma cells growth” [Steroids 129 (2018) 24-34]

Publication date: August 2018Source: Steroids, Volume 136Author(s): Vladimir A. Zolottsev, Yaroslav V. Tkachev, Alexandra S. Latysheva, Vladimir A. Kostin, Roman A. Novikov, Vladimir P. Timofeev, Galina E. Morozevich, Alexey V. Kuzikov, Victoria V. Shumyantseva, Alexander Y. Misharin
Source: Steroids - Category: Drugs & Pharmacology Source Type: research